Luoxin pharmaceutical: delayed disclosure of the first quarter report of 2022
Luoxin pharmaceutical announced that affected by the epidemic situation of novel coronavirus pneumonia, some regions implemented epidemic prevention and control measures, which affected the progress of the company's preparation of the first quarter report of 2022. Now, the first quarter report of 2022 is postponed to be disclosed on April 30, 2022.
This text is a result of machine translation.
Related companies：
In-depth
Communication
Saudi's First Night Club - Alcohol Free
In most countries, visiting nightclubs has become a common pastime for many young people, and such venues can easily be found in any corner of the city. However, you would never expect that the following scene takes place in Riyadh, Saudi Arabia.
Sep 04, 2024 09:23 PM
Briefing May 23, 2022 12:38 PM
· Healthcare
Aimeike signs distribution cooperation framework agreement with South Korea huons BP
Briefing Feb 25, 2022 09:58 AM
· Healthcare
The steel sector strengthened significantly
Dec 11, 2023 08:49 PM
Nov 16, 2022 05:19 PM
Nov 07, 2022 04:27 PM
Aug 29, 2022 05:45 PM
Briefing Dec 09, 2021 10:39 AM
Baijiu plate strength, mouth cellar line exceeds 10%
Briefing Oct 22, 2021 10:13 PM
· Real Estate
AMEC: the capital increase and acquisition of part of the equity of hoons biopharma in South Korea have been completed
Briefing Oct 19, 2021 06:56 AM
· Financials
The investment banking business was strictly supervised, and seven securities companies received fines
Briefing Oct 17, 2021 06:26 PM
· Healthcare
The first batch of "Mao" concept achievements were released, with a year-on-year growth of more than 50%
Briefing Sep 24, 2021 11:28 AM
· Healthcare
The medical and American plate rose sharply
Briefing Aug 23, 2021 07:46 PM
· Healthcare
AMEC: the net profit in the first half of the year was 425 million yuan, a year-on-year increase of 188.86%
Briefing Jul 08, 2021 07:41 PM
· Financials
Aimike's reply to the letter of concern: after obtaining the equity of huons bio, it will not have a significant adverse impact on the company's production and operation
See more
Read next
Insight
In-depth
Consumer Staples · Analysis
Mexicans Who Can’t Afford Tacos Flock to Chinese Restaurants
Updated 8 hours ago
Insight
In-depth
Insight
In-depth
Insight
In-depth
Automotive · Analysis
360 Billion: How Can Chinese Companies Grow Together with Africa
Sep 27, 2024 06:30 PM